| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.77B | +22.7% |
| Cost of Revenue | $1.23B | +21.5% |
| Gross Profit | $534.2M | +25.5% |
| R&D Expense | $142.4M | +4.5% |
| SG&A Expense | $97.3M | -8.8% |
| Operating Income | $25.9M | +140.7% |
| Pre-tax Income | $13.9M | +118.2% |
| Income Tax | $17.7M | +221.8% |
| Net Income | -$3.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $226.6M | +28.7% |
| Short-term Investments | $3.8M | -34.0% |
| Accounts Receivable | $370.1M | +20.8% |
| Current Assets | $656.0M | +17.3% |
| Total Assets | $1.72B | +0.6% |
| Current Liabilities | $485.6M | +14.5% |
| Stockholders' Equity | $1.05B | -0.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $184.3M | +118.5% |
| Capital Expenditures | $35.2M | +9.4% |
| Investing Cash Flow | -$30.1M | -150.5% |
| Financing Cash Flow | -$100.0M | +25.7% |
| Free Cash Flow | $149.2M | +185.6% |
| +95.4% |
| EPS (Basic) | -$0.01 | +95.8% |
| EPS (Diluted) | -$0.01 | +95.8% |